 | • レポートコード：MRC2012B0530 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、イロプロスト治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。イロプロスト治療薬の種類別市場規模（吸入、静脈内）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Actelion (J & J)、Bayer AG、 ・地域別グローバル市場分析 2015年-2020年 ・イロプロスト治療薬の北米市場（アメリカ、カナダ、メキシコ） ・イロプロスト治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・イロプロスト治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・イロプロスト治療薬の南米市場（ブラジル、アルゼンチン） ・イロプロスト治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：吸入、静脈内 ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Iloprost Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Iloprost Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -1.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 90 million by 2025, from USD 96 million in 2019.
Market segmentation
Iloprost Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Iloprost Drugs market has been segmented into:
Inhaled
Intravenous
By Application, Iloprost Drugs has been segmented into:
Hospital
Clinic
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Iloprost Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Iloprost Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Iloprost Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Iloprost Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Iloprost Drugs Market Share Analysis
Iloprost Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Iloprost Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Iloprost Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Iloprost Drugs are:
Actelion (J & J)
Bayer AG
Among other players domestic and global, Iloprost Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Iloprost Drugs Market Overview
1.1 Product Overview and Scope of Iloprost Drugs
1.2 Classification of Iloprost Drugs by Type
1.2.1 Global Iloprost Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Iloprost Drugs Revenue Market Share by Type in 2019
1.2.3 Inhaled
1.2.4 Intravenous
1.3 Global Iloprost Drugs Market by Application
1.3.1 Overview: Global Iloprost Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Iloprost Drugs Market by Regions
1.4.1 Global Iloprost Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Iloprost Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Iloprost Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Iloprost Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Iloprost Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Iloprost Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Iloprost Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Actelion (J & J)
2.1.1 Actelion (J & J) Details
2.1.2 Actelion (J & J) Major Business
2.1.3 Actelion (J & J) SWOT Analysis
2.1.4 Actelion (J & J) Product and Services
2.1.5 Actelion (J & J) Iloprost Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business
2.2.3 Bayer AG SWOT Analysis
2.2.4 Bayer AG Product and Services
2.2.5 Bayer AG Iloprost Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Iloprost Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Iloprost Drugs Players Market Share
3.2.2 Top 10 Iloprost Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Iloprost Drugs Revenue and Market Share by Regions
4.2 North America Iloprost Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Iloprost Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Iloprost Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Iloprost Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Iloprost Drugs Revenue and Growth Rate (2015-2020)
5 North America Iloprost Drugs Revenue by Countries
5.1 North America Iloprost Drugs Revenue by Countries (2015-2020)
5.2 USA Iloprost Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Iloprost Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Iloprost Drugs Revenue and Growth Rate (2015-2020)
6 Europe Iloprost Drugs Revenue by Countries
6.1 Europe Iloprost Drugs Revenue by Countries (2015-2020)
6.2 Germany Iloprost Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Iloprost Drugs Revenue and Growth Rate (2015-2020)
6.4 France Iloprost Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Iloprost Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Iloprost Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Iloprost Drugs Revenue by Countries
7.1 Asia-Pacific Iloprost Drugs Revenue by Countries (2015-2020)
7.2 China Iloprost Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Iloprost Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Iloprost Drugs Revenue and Growth Rate (2015-2020)
7.5 India Iloprost Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Iloprost Drugs Revenue and Growth Rate (2015-2020)
8 South America Iloprost Drugs Revenue by Countries
8.1 South America Iloprost Drugs Revenue by Countries (2015-2020)
8.2 Brazil Iloprost Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Iloprost Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Iloprost Drugs by Countries
9.1 Middle East & Africa Iloprost Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Iloprost Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Iloprost Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Iloprost Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Iloprost Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Iloprost Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Iloprost Drugs Market Forecast by Type (2019-2024)
10.3 Inhaled Revenue Growth Rate (2015-2025)
10.4 Intravenous Revenue Growth Rate (2015-2025)
11 Global Iloprost Drugs Market Segment by Application
11.1 Global Iloprost Drugs Revenue Market Share by Application (2015-2020)
11.2 Iloprost Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
12 Global Iloprost Drugs Market Size Forecast (2021-2025)
12.1 Global Iloprost Drugs Market Size Forecast (2021-2025)
12.2 Global Iloprost Drugs Market Forecast by Regions (2021-2025)
12.3 North America Iloprost Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Iloprost Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Iloprost Drugs Revenue Market Forecast (2021-2025)
12.6 South America Iloprost Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Iloprost Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Iloprost Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Iloprost Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Iloprost Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Iloprost Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Iloprost Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Actelion (J & J) Corporate Information, Location and Competitors
Table 7. Actelion (J & J) Iloprost Drugs Major Business
Table 8. Actelion (J & J) Iloprost Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Actelion (J & J) SWOT Analysis
Table 10. Actelion (J & J) Iloprost Drugs Product and Solutions
Table 11. Actelion (J & J) Iloprost Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Bayer AG Corporate Information, Location and Competitors
Table 13. Bayer AG Iloprost Drugs Major Business
Table 14. Bayer AG Iloprost Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Bayer AG SWOT Analysis
Table 16. Bayer AG Iloprost Drugs Product and Solutions
Table 17. Bayer AG Iloprost Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Global Iloprost Drugs Revenue (Million USD) by Players (2015-2020)
Table 19. Global Iloprost Drugs Revenue Share by Players (2015-2020)
Table 20. Global Iloprost Drugs Revenue (Million USD) by Regions (2015-2020)
Table 21. Global Iloprost Drugs Revenue Market Share by Regions (2015-2020)
Table 22. North America Iloprost Drugs Revenue by Countries (2015-2020)
Table 23. North America Iloprost Drugs Revenue Market Share by Countries (2015-2020)
Table 24. Europe Iloprost Drugs Revenue (Million USD) by Countries (2015-2020)
Table 25. Asia-Pacific Iloprost Drugs Revenue (Million USD) by Countries (2015-2020)
Table 26. South America Iloprost Drugs Revenue by Countries (2015-2020)
Table 27. South America Iloprost Drugs Revenue Market Share by Countries (2015-2020)
Table 28. Middle East and Africa Iloprost Drugs Revenue (Million USD) by Countries (2015-2020)
Table 29. Middle East and Africa Iloprost Drugs Revenue Market Share by Countries (2015-2020)
Table 30. Global Iloprost Drugs Revenue (Million USD) by Type (2015-2020)
Table 31. Global Iloprost Drugs Revenue Share by Type (2015-2020)
Table 32. Global Iloprost Drugs Revenue Forecast by Type (2021-2025)
Table 33. Global Iloprost Drugs Revenue by Application (2015-2020)
Table 34. Global Iloprost Drugs Revenue Share by Application (2015-2020)
Table 35. Global Iloprost Drugs Revenue Forecast by Application (2021-2025)
Table 36. Global Iloprost Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Iloprost Drugs Picture
Figure 2. Global Iloprost Drugs Revenue Market Share by Type in 2019
Figure 3. Inhaled Picture
Figure 4. Intravenous Picture
Figure 5. Iloprost Drugs Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Global Iloprost Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Iloprost Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Iloprost Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Iloprost Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Iloprost Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Iloprost Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Iloprost Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Iloprost Drugs Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Iloprost Drugs Revenue Market Share in 2019
Figure 17. Global Top 10 Players Iloprost Drugs Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Iloprost Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Iloprost Drugs Revenue Market Share by Regions (2015-2020)
Figure 21. Global Iloprost Drugs Revenue Market Share by Regions in 2018
Figure 22. North America Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 23. Europe Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 25. South America Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 27. North America Iloprost Drugs Revenue Market Share by Countries (2015-2020)
Figure 28. North America Iloprost Drugs Revenue Market Share by Countries in 2019
Figure 29. USA Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Canada Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Europe Iloprost Drugs Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Iloprost Drugs Revenue Market Share by Countries in 2019
Figure 34. Germany Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 35. UK Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 36. France Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Russia Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Italy Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Iloprost Drugs Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Iloprost Drugs Revenue Market Share by Countries in 2019
Figure 41. China Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Japan Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Korea Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 44. India Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 46. South America Iloprost Drugs Revenue Market Share by Countries (2015-2020)
Figure 47. South America Iloprost Drugs Revenue Market Share by Countries in 2019
Figure 48. Brazil Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Iloprost Drugs Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Iloprost Drugs Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 53. UAE Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Iloprost Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Global Iloprost Drugs Revenue Share by Type (2015-2020)
Figure 57. Global Iloprost Drugs Revenue Share by Type in 2019
Figure 58. Global Iloprost Drugs Market Share Forecast by Type (2021-2025)
Figure 59. Global Inhaled Revenue Growth Rate (2015-2020)
Figure 60. Global Intravenous Revenue Growth Rate (2015-2020)
Figure 61. Global Iloprost Drugs Revenue Share by Application (2015-2020)
Figure 62. Global Iloprost Drugs Revenue Share by Application in 2019
Figure 63. Global Iloprost Drugs Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Clinic Revenue Growth Rate (2015-2020)
Figure 66. Global Iloprost Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Iloprost Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Iloprost Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Iloprost Drugs Revenue Market Forecast (2021-2025)
Figure 70. Europe Iloprost Drugs Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Iloprost Drugs Revenue Market Forecast (2021-2025)
Figure 72. South America Iloprost Drugs Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Iloprost Drugs Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…- タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- 静脈内（IV）鉄剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Intravenous (IV) Iron Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1716.1 million by 2025, from USD 1472.2 million in 2019. The Intraven…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…